PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China.\', \'Sinovac Biotech Co., Ltd, Beijing 100085, China.\', \'Beijing WanTai Biological Pharmacy Enterprise Co., Ltd, Beijing 102206, China.\', \'Artron Bioresearch Inc., Burnaby, BC V5A1M6, Canada.\', \'Institute of Medicinal Plant Development, Chinese Academy of Medical Science and Peking Union Medical College, Beijing 100193, China.\', \'Jianxuan Business Center, Tianjin 300110, China.\', \'Sinovac Life Sciences Co., Ltd, Beijing 100085, China.\', \'National Institute For Viral Disease Control and Prevention, Chinese Center For Disease Control and Prevention, Beijing 102206, China. Electronic address: bisl@ivdc.chinacdc.cn.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0264-410X(21)00071-210.1016/j.vaccine.2021.01.044
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 33516600
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Recombinant SARS-CoV-2 RBD with a built in T helper epitope induces strong neutralization antibody response.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33516600>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33516600>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all